跳至主要内容
临床试验/NCT01447095
NCT01447095已完成2 期

Effect of Prostacyclin Infusion on Cerebral Vessels, Cerebral Bloodflow and Cerebral Metabolism in Patients With Subarachnoid Haemorrhage

Rune Rasmussen1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2011年10月最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
已完成
入组人数
90
试验地点
1
主要终点
Radiographic vasospasm measured by CT perfusion

研究概览

简要总结

The purpose of this study is to determine whether prostacyclin is effective in prevention of cerebral vasospasm in patients with subarachnoidal hemorrhage (SAH).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • SAH verified by CT
  • Aneurysm identified and treated
  • Fisher grade 3 + 4
  • WFNS grade 1-4 (World Federation of Neurosurgical Societies )

排除标准

  • Pregnancy/lactation
  • Heard failure
  • Kidney failure
  • Liver failure
  • Hemorrhagic diathesis

研究组 & 干预措施

High dose prostacyclin

Active Comparator

干预措施: Prostacyclin 2 ng/kg/min (Drug)

Low dose prostacyclin

Active Comparator

干预措施: Prostacyclin 1 ng/kg/min (Drug)

Placebo

Placebo Comparator

干预措施: Placebo (Drug)

结局指标

主要结局

Radiographic vasospasm measured by CT perfusion

时间窗: Day 8 (+/- 1 day) after aneurysm treatment

Changes in regional cerebral blood flow from baseline in the arterial territories of the anterior cerebral artery, medial cerebral artery and the posterior cerebral artery

次要结局

  • Cerebral metabolism measured by microdialysis(every 2. hour day 3-10 after aneurysm treatment)
  • Clinical vasospasm(day 5-10 after SAH)
  • Glasgow outcome scale (GOS) at 3 months(3 months efter SAH)
  • Radiographic vasospasm measured by CT angiography(Measured day 8 +/- 1 day)
  • Brain tissue oxygen (PtiO2)(continuous measurement day 3-10 after SAH)
  • Mean arterial pressure (MAP)(Continuous day 1-10 after SAH)
  • Level of brain damage biomarker(daily day 4-11 after SAH)

研究者

申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Rune Rasmussen

MD, Sponsor-Investigator

Rigshospitalet, Denmark

研究点 (1)

Loading locations...

相似试验